Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?
The global supply chain for bovine and porcine heparin and regulatory considerations are examined.
David Keire
Advertisement
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles by David Keire
Advertisement
Latest Updated Articles
Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?Published: November 2nd 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
